Effects of stress management on testosterone levels in women with early-stage breast cancer

D. G. Cruess, Michael H Antoni, Mahendra Kumar, B. McGregor, S. Alferi, A. E. Boyers, Charles S Carver, K. Kilbourn

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

We examined the effects of a 10-week, group-based cognitive-behavioral stress management (CBSM) intervention on serum testosterone levels in women with Stage 1 or 2 breast cancer. At 4 to 8 weeks postsurgery, participants were randomized to CBSM (n=24) or to a wait-list control group (n=10). Free and total testosterone was assessed via radioimmunoassay before and after the study period. The participants also completed a questionnaire assessing the degree to which living with breast cancer had led to social and emotional benefits in their life. We observed significant decreases in testosterone levels in the CBSM group and no change in the controls. Decreases in testosterone were related to increases in positive contributions. These findings suggest that a short-term psychological intervention can help modulate androgen functioning, and these changes are related to enhanced benefit finding observed among women with breast cancer participating in CBSM.

Original languageEnglish
Pages (from-to)194-207
Number of pages14
JournalInternational Journal of Behavioral Medicine
Volume8
Issue number3
StatePublished - Oct 22 2001

Fingerprint

Testosterone
Breast Neoplasms
Androgens
Radioimmunoassay
Psychology
Control Groups
Serum

Keywords

  • Benefit finding
  • Breast cancer
  • CBSM
  • Testosterone

ASJC Scopus subject areas

  • Psychology(all)
  • Clinical Psychology

Cite this

Effects of stress management on testosterone levels in women with early-stage breast cancer. / Cruess, D. G.; Antoni, Michael H; Kumar, Mahendra; McGregor, B.; Alferi, S.; Boyers, A. E.; Carver, Charles S; Kilbourn, K.

In: International Journal of Behavioral Medicine, Vol. 8, No. 3, 22.10.2001, p. 194-207.

Research output: Contribution to journalArticle

@article{cb474f57c3bd48edb29c3080c7329eb8,
title = "Effects of stress management on testosterone levels in women with early-stage breast cancer",
abstract = "We examined the effects of a 10-week, group-based cognitive-behavioral stress management (CBSM) intervention on serum testosterone levels in women with Stage 1 or 2 breast cancer. At 4 to 8 weeks postsurgery, participants were randomized to CBSM (n=24) or to a wait-list control group (n=10). Free and total testosterone was assessed via radioimmunoassay before and after the study period. The participants also completed a questionnaire assessing the degree to which living with breast cancer had led to social and emotional benefits in their life. We observed significant decreases in testosterone levels in the CBSM group and no change in the controls. Decreases in testosterone were related to increases in positive contributions. These findings suggest that a short-term psychological intervention can help modulate androgen functioning, and these changes are related to enhanced benefit finding observed among women with breast cancer participating in CBSM.",
keywords = "Benefit finding, Breast cancer, CBSM, Testosterone",
author = "Cruess, {D. G.} and Antoni, {Michael H} and Mahendra Kumar and B. McGregor and S. Alferi and Boyers, {A. E.} and Carver, {Charles S} and K. Kilbourn",
year = "2001",
month = "10",
day = "22",
language = "English",
volume = "8",
pages = "194--207",
journal = "International Journal of Behavioral Medicine",
issn = "1070-5503",
publisher = "Routledge",
number = "3",

}

TY - JOUR

T1 - Effects of stress management on testosterone levels in women with early-stage breast cancer

AU - Cruess, D. G.

AU - Antoni, Michael H

AU - Kumar, Mahendra

AU - McGregor, B.

AU - Alferi, S.

AU - Boyers, A. E.

AU - Carver, Charles S

AU - Kilbourn, K.

PY - 2001/10/22

Y1 - 2001/10/22

N2 - We examined the effects of a 10-week, group-based cognitive-behavioral stress management (CBSM) intervention on serum testosterone levels in women with Stage 1 or 2 breast cancer. At 4 to 8 weeks postsurgery, participants were randomized to CBSM (n=24) or to a wait-list control group (n=10). Free and total testosterone was assessed via radioimmunoassay before and after the study period. The participants also completed a questionnaire assessing the degree to which living with breast cancer had led to social and emotional benefits in their life. We observed significant decreases in testosterone levels in the CBSM group and no change in the controls. Decreases in testosterone were related to increases in positive contributions. These findings suggest that a short-term psychological intervention can help modulate androgen functioning, and these changes are related to enhanced benefit finding observed among women with breast cancer participating in CBSM.

AB - We examined the effects of a 10-week, group-based cognitive-behavioral stress management (CBSM) intervention on serum testosterone levels in women with Stage 1 or 2 breast cancer. At 4 to 8 weeks postsurgery, participants were randomized to CBSM (n=24) or to a wait-list control group (n=10). Free and total testosterone was assessed via radioimmunoassay before and after the study period. The participants also completed a questionnaire assessing the degree to which living with breast cancer had led to social and emotional benefits in their life. We observed significant decreases in testosterone levels in the CBSM group and no change in the controls. Decreases in testosterone were related to increases in positive contributions. These findings suggest that a short-term psychological intervention can help modulate androgen functioning, and these changes are related to enhanced benefit finding observed among women with breast cancer participating in CBSM.

KW - Benefit finding

KW - Breast cancer

KW - CBSM

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=0034788257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034788257&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034788257

VL - 8

SP - 194

EP - 207

JO - International Journal of Behavioral Medicine

JF - International Journal of Behavioral Medicine

SN - 1070-5503

IS - 3

ER -